US2007021326A1PendingUtilityA1

Composition and its Therapeutic Use

Assignee: INSIGNION HOLDINGS LTDPriority: May 29, 2002Filed: Sep 25, 2006Published: Jan 25, 2007
Est. expiryMay 29, 2022(expired)· nominal 20-yr term from priority
A61K 45/06A61K 38/28A61P 35/00A61K 8/19A61Q 7/00A61K 36/28A61K 8/64A61K 38/27A61K 8/676A61K 31/375A61K 31/51A61Q 19/00A61K 31/4415
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A composition having a variety of therapeutic and cosmetic uses comprises: (i) a vitamin; (ii) a metal salt that provides metal ions in vivo; and (iii) insulin or a growth hormone. Such a composition is useful for treating, for example, genetic disorders, skin diseases, cancer and viral infections.

Claims

exact text as granted — not AI-modified
1 . A composition comprising: 
 (i) a vitamin;    (ii) a metal salt that provides metal ions in vivo; and    (iii) insulin or a growth hormone.    
   
   
       2 . A composition according to  claim 1 , wherein the metal ions are Ca ions.  
   
   
       3 . A composition according to  claim 2 , which comprises vitamin C.  
   
   
       4 . A composition according to  claim 3 , which comprises a vitamin B compound selected from vitamins B1, B2, PP, B5 and B6.  
   
   
       5 . A composition according to  claim 4 , which additionally comprises an antihistamine.  
   
   
       6 . A composition according to  claim 5 , which additionally comprises camomile or an active component thereof.  
   
   
       7 . A composition according to  claim 6 , wherein said active component is apigenin.  
   
   
       8 . A composition according to  claim 6 , which comprises insulin.  
   
   
       9 . A composition according to  claim 8 , which additionally comprises phenol.  
   
   
       10 . A composition according to  claim 9 , which comprises an insulin-phenol complex.  
   
   
       11 . A composition according to  claim 6 , which additionally comprises phenol.  
   
   
       12 . A composition according to  claim 10 , which is an aqueous composition suitable for injection.  
   
   
       13 . A composition according to  claim 10 , which is adapted for oral administration, and which does not contain insulin.  
   
   
       14 . A method for treating a genetic disorder, comprising administering to a patient in need of such treatment an effective amount of a composition according to  claim 1 .  
   
   
       15 . A method for treating a skin disease, comprising administering to a patient in need of such treatment an effective amount of a composition according to  claim 1 .  
   
   
       16 . A method according to  claim 15 , wherein the disease is selected from psoriasis, scleroderma and pemphigus.  
   
   
       17 . A method for treating cancer, comprising administering to a patient in need of such treatment an effective amount of a composition according to  claim 1 .  
   
   
       18 . A method for treating AIDS, comprising administering to a patient in need of such treatment an effective amount of a composition according to  claim 1 .  
   
   
       19 . A method for treating a disease caused by a RNA or DNA virus, or a retrovirus, comprising administering to a patient in need of such treatment an effective amount of a composition according to  claim 1 .  
   
   
       20 . A method for treating a disease caused by a coronavirus, comprising administering to a patient in need of such treatment an effective amount of a composition according to  claim 1 .  
   
   
       21 . A method according to  claim 19 , wherein the disease is a fowl's disease.  
   
   
       22 . A method according to  claim 20 , wherein the disease is a fowl's disease.  
   
   
       23 . A cosmetic composition comprising the composition of  claim 1 .  
   
   
       24 . A composition according to  claim 1 , which comprises vitamin C.  
   
   
       25 . A composition according to  claim 1 , which comprises a vitamin B compound selected from vitamins B1, B2, PP, B5 and B6.  
   
   
       26 . A composition according to  claim 1 , which additionally comprises an antihistamine.  
   
   
       27 . A composition according to  claim 24 , which additionally comprises an antihistamine.  
   
   
       28 . A composition according to  claim 1 , which additionally comprises camomile or an active component thereof.  
   
   
       29 . A composition according to  claim 7 , which comprises insulin.  
   
   
       30 . A composition according to  claim 1 , which is an aqueous composition suitable for injection.  
   
   
       31 . A composition according to  claim 1 , which is adapted for oral administration, and which does not contain insulin.

Join the waitlist — get patent alerts

Track US2007021326A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.